2024

Canadian Lung Cancer Conference
February 9, 2024 (approved for 6.5 hours)

Canadian Conference on Lymphoproliferative Disorders
March 22-24, 2024 (approved for 10.5 hours)

Canadian Breast Cancer Conference
April 5-6, 2024 (approved for 12 hours)

Vancouver Island Oncology Conference 2024
April 12-14, 2024 (approved for 9 hours)

West Coast Sarcoma Conference 2024
April 19-20, 2024 (approved for 9 hours)

BC Genitourinary Multidisciplinary Care Conference 2024
April 19-21, 2024 (approved for 10.5 hours)

Horizon Health Network Cancer Survivorship Conference 2024
June 14-15, 2024 (approved for 12 hours)

Canadian Conference on Meylodysplastic Syndrome @ Acute Myeloid Leukaemia (CCMDS AML)
September 20-22, 2024 (approved for 17 hours)

Canadian Multidisciplinary Hepatocellular Carcinoma Conference
October 4-5, 2024 (approved for 7.25 hours)

Conference on Hematology and Oncology (COHO)
November 1-2, 2024 (approved for 13.5 hours)

Precision Oncology & Experimental Therapeutics Congress
November 7-8, 2024 (approved for 10 hours)

2023

SHOW: Symposium on Hepatic Oncology at Whistler
January 26-28, 2023 (approved for 16 hours)

Canadian Lung Cancer Conference
February 2-3, 2023 (approved for 6.5 hours)

Canadian Lung Cancer Conference BC Genitourinary Multidisciplinary Care Conference
February 24-26, 2023 (approved for 10.5 hours)

Canadian Conference on Lymphoproliferative Disorders (CCOLD)
March 24-26, 2023 (approved for 10.5 hours)

Canadian Multidisciplinary Hepatocellular Carcinoma Conference
May 12, 2023 (approved for 6 hours)

Precision Oncology & Experimental Therapeutics Congress
October 12-13, 2023 (approved for 12 hours)

I WANT A NEW DRUG: current cancer treatment landscape - an overview of the Canadian cancer treatment review process
October 30, 2023 (approved for 2 hours - section 3 credits)

Conference on Hematology and Oncology (COHO)
November 3-4, 2023 (approved for 13.5 hours)

2022

Canadian Lung Cancer Conference
February 4, 2022 (approved for 6.5 hours)

Canadian Conference on Lymphoproliferative Disorders
March 25-27, 2022 (approved for 10.5 hours)

Conference on Hematology and Oncology (COHO)
June 24-25, 2022 (approved for 13 hours)

Canadian Lung Cancer Conference
July 6-7, 2022 (approved for 4 hours)

BC Cancer Summit: Transformation, Adaptation and Inclusion in Cancer Care and Research
November 24-26, 2022 (approved for 12.25 hours)

2021

Canadian Lung Cancer Virtual Conference
February 5, 2021 (approved for 3.5 hours)

JEWEL: Jumping into Real-World Evidence Learning Program in Advanced Breast Cancer
February 1, 2021 to February 1, 2022 (approved for 1 hour)

Clinical Insights into Ovarian Cancer Management
September 16, 2021 (approved for 1.5 hours)
September 21, 2021 French session (approved for 1.5 hours)
September 21, 2021 (approved for 1.5 hours)

Clinical Insights in Ovarian Cancer Management
September 9, 2021 (approved for 1 hour)

Melanoma Virtual Speaker Tour - Standing the test of time: Long-term outcomes in the management of metastatic melanoma
November 22, 2021 (approved for 1 hour)

BC Cancer Summit 2021
November 18-20, 2021 (approved for 5.25 hours)

2020

Canadian Lung Cancer Conference
February 7, 2020 (approved for 6.5 hours)

The Place of IO in First-Line Advanced NSCLS
February 1, 2020 to February 1, 2021 (approved for 1 hour) 

Exploring Options in Metastatic RCC
May 13, 2020 to May 12, 2021 (approved for 1 hour)

Examining an evolving treatment landscape: Contextualizing the role of immunotherapy as a first line option in thoracic cancer
October 20, 2020 to October 20, 2021 (approved for 1 hour)

Virtual Cancer Cachexia Conference 2020
September 10-11, 2020 (approved for 8 hours)

POET Virtual Congress 2.0
October 22-23, 2020 (approved for 10 hours)

Conference on Hematology & Oncology
November 27-28, 2020 (approved for 11.5 hours)

Exploring Options in Metastatic RCC (re-accreditation)
November 3, 2020 to November 3, 2021 (approved for 1 hour)

Adjuvant Melanoma Treatment - Can We Improve Patient Outcomes?
November 24, 2020 to November 24, 2021 (approved for 1 hour)

Clinical Implications of Immuno-oncology (I-O) Combination Strategies: The Rationale and Evidence Supporting I-O Based Combinations (multi-modular program
November 24, 2020 to November 24, 2021 (approved for 1 or 1.5 hours section 3 CME credits)

2019

Canadian Summer Oncology Update Conference
June 21-22, 2019 (approved for 11 hours)

The 2019 Eastern Canada Colorectal Consensus Conference (ECS)
September 19-21, 2019 (approved for 11 hours)

Canadian Conference on Myelodysplastic Syndromes and Acute Myeloid Leukemia
September 19-21, 2019 (approved for 14.50 hours)

LHIN4 Day in Breast Cancer 2019
November 1, 2019 (approved for 4.5 hours)